SomnoMed Limited (SOM.AX)
AUD 0.43
(0.0%)
AUD 0.43
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 24.78 Million AUD | -38.18% |
| 2023 | 40.08 Million AUD | 32.28% |
| 2022 | 30.3 Million AUD | 26.23% |
| 2021 | 24 Million AUD | -13.82% |
| 2020 | 27.85 Million AUD | 64.54% |
| 2019 | 16.93 Million AUD | 30.95% |
| 2018 | 12.92 Million AUD | 26.05% |
| 2017 | 10.25 Million AUD | 32.55% |
| 2016 | 7.73 Million AUD | 23.96% |
| 2015 | 6.24 Million AUD | -5.03% |
| 2014 | 6.57 Million AUD | -2.32% |
| 2013 | 6.72 Million AUD | 98.4% |
| 2012 | 3.39 Million AUD | 34.87% |
| 2011 | 2.51 Million AUD | 15.19% |
| 2010 | 2.18 Million AUD | 28.06% |
| 2009 | 1.7 Million AUD | 71.21% |
| 2008 | 995.72 Thousand AUD | 26.76% |
| 2007 | 785.5 Thousand AUD | -5.9% |
| 2006 | 834.71 Thousand AUD | 16.53% |
| 2005 | 716.3 Thousand AUD | -8.73% |
| 2004 | 784.78 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 24.78 Million AUD | 0.0% |
| 2024 FY | 24.78 Million AUD | -38.18% |
| 2024 Q2 | 34.01 Million AUD | 0.0% |
| 2023 FY | 40.08 Million AUD | 32.28% |
| 2023 Q4 | 40.08 Million AUD | 0.0% |
| 2023 Q2 | 39.63 Million AUD | 0.0% |
| 2022 Q4 | 30.3 Million AUD | 0.0% |
| 2022 Q2 | 25.13 Million AUD | 0.0% |
| 2022 FY | 30.3 Million AUD | 26.23% |
| 2021 FY | 24 Million AUD | -13.82% |
| 2021 Q2 | 25.28 Million AUD | 0.0% |
| 2021 Q4 | 24 Million AUD | 0.0% |
| 2020 Q2 | 22.61 Million AUD | 0.0% |
| 2020 Q4 | 27.85 Million AUD | 0.0% |
| 2020 FY | 27.85 Million AUD | 64.54% |
| 2019 Q4 | 16.93 Million AUD | 0.0% |
| 2019 Q2 | 16.99 Million AUD | 0.0% |
| 2019 FY | 16.93 Million AUD | 30.95% |
| 2018 Q2 | 11.55 Million AUD | 0.0% |
| 2018 FY | 12.92 Million AUD | 26.05% |
| 2018 Q4 | 12.92 Million AUD | 0.0% |
| 2017 Q4 | 10.25 Million AUD | 0.0% |
| 2017 Q2 | 8.6 Million AUD | 0.0% |
| 2017 FY | 10.25 Million AUD | 32.55% |
| 2016 Q4 | 7.73 Million AUD | 0.0% |
| 2016 FY | 7.73 Million AUD | 23.96% |
| 2016 Q2 | 6.69 Million AUD | 0.0% |
| 2015 FY | 6.24 Million AUD | -5.03% |
| 2015 Q2 | 5.17 Million AUD | 0.0% |
| 2015 Q4 | 6.24 Million AUD | 0.0% |
| 2014 Q2 | 6.05 Million AUD | 0.0% |
| 2014 Q4 | 6.57 Million AUD | 0.0% |
| 2014 FY | 6.57 Million AUD | -2.32% |
| 2013 FY | 6.72 Million AUD | 98.4% |
| 2013 Q2 | 2.84 Million AUD | 0.0% |
| 2013 Q4 | 4.53 Million AUD | 0.0% |
| 2012 Q4 | 3.39 Million AUD | 0.0% |
| 2012 FY | 3.39 Million AUD | 34.87% |
| 2011 Q4 | 2.51 Million AUD | 0.0% |
| 2011 FY | 2.51 Million AUD | 15.19% |
| 2010 FY | 2.18 Million AUD | 28.06% |
| 2010 Q4 | 2.18 Million AUD | 0.0% |
| 2009 FY | 1.7 Million AUD | 71.21% |
| 2009 Q4 | 1.7 Million AUD | 0.0% |
| 2008 FY | 995.72 Thousand AUD | 26.76% |
| 2008 Q4 | 995.72 Thousand AUD | 0.0% |
| 2007 Q4 | 785.5 Thousand AUD | 0.0% |
| 2007 FY | 785.5 Thousand AUD | -5.9% |
| 2006 FY | 834.71 Thousand AUD | 16.53% |
| 2006 Q4 | 834.71 Thousand AUD | 0.0% |
| 2005 FY | 716.3 Thousand AUD | -8.73% |
| 2005 Q4 | 716.3 Thousand AUD | 0.0% |
| 2004 FY | 784.78 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 49.519% |
| Adherium Limited | 3.4 Million AUD | -627.392% |
| Aroa Biosurgery Limited | 14.77 Million AUD | -67.678% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -1814.449% |
| Anteris Technologies Ltd | 17.03 Million AUD | -45.433% |
| Control Bionics Limited | 2.75 Million AUD | -797.973% |
| CardieX Limited | 8.56 Million AUD | -189.414% |
| Compumedics Limited | 22.14 Million AUD | -11.886% |
| Cochlear Limited | 904.6 Million AUD | 97.261% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -256.568% |
| Cyclopharm Limited | 13.65 Million AUD | -81.479% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -354.216% |
| Nova Eye Medical Limited | 8.55 Million AUD | -189.763% |
| HeraMED Limited | 1.5 Million AUD | -1545.519% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 0.895% |
| ImpediMed Limited | 6.24 Million AUD | -296.932% |
| InhaleRx Limited | 911.41 Thousand AUD | -2618.909% |
| LBT Innovations Limited | 5.5 Million AUD | -349.9% |
| Micro-X Limited | 12.63 Million AUD | -96.141% |
| Neurotech International Limited | 314.69 Thousand AUD | -7774.348% |
| OncoSil Medical Limited | 1.98 Million AUD | -1150.281% |
| PolyNovo Limited | 37.04 Million AUD | 33.103% |
| Respiri Limited | 3.55 Million AUD | -597.261% |
| Universal Biosensors, Inc. | 10.61 Million AUD | -133.502% |
| Uscom Limited | 2.07 Million AUD | -1095.061% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -795.602% |